vinpocetine has been researched along with Chronic Disease in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (22.22) | 18.7374 |
| 1990's | 1 (5.56) | 18.2507 |
| 2000's | 12 (66.67) | 29.6817 |
| 2010's | 1 (5.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Achiemere, G; Alpini, D; Hahn, A; Klement, V; Radkova, L; Strouhal, J | 1 |
| Chelysheva, LV; Doronin, BM; Klimova, LA; Kornach, NV; Popova, TF; Volkova, II | 1 |
| Grigor'eva, AN; Nesterova, MV | 1 |
| Chukanova, EI; Levin, IaI; Nikonov, AA; Petrova, EA; Peverennova, IE; Skoromets, AA; Spirin, NN; Tanashian, MM | 1 |
| Afon'kin, VIu; Dobretsov, KG; Sipkin, AV | 1 |
| Alifirova, VM; Vaizova, OE; Vengerovsky, AI | 1 |
| Alexy, T; Czopf, J; Horváth, B; Késmárky, G; Márton, Z; Nagy, F; Szapáry, L; Szóts, M; Tóth, K | 1 |
| Balkay, L; Bereczki, D; Bönöczk, P; Boros, I; Csiba, L; Emri, M; Fekete, I; Galuska, L; Gulyás, B; Kerényi, L; Lehel, S; Márián, T; Molnár, T; Nagy, Z; Szakáll, S; Szilágyi, G; Trón, L; Varga, J; Vas, A | 1 |
| Alexy, T; Czopf, I; Horvath, B; Kesmarky, G; Marton, Z; Nagy, F; Sapary, L; Toth, K; Zsots, M | 1 |
| Bagoly, E; Fehér, G; Szapáry, L | 1 |
| Alifirova, VM; Vaizova, OE; Vengerovskiĭ, AI | 1 |
| Murashko, NK | 1 |
| Eninia, GI; Purinia, IV; Timofeeva, TN | 1 |
| Horváth, S | 1 |
| Karadzhaeva, GB; Krivchenko, AI; Vaĭnshteĭn, GB | 1 |
| Burtsev, EM; Savkov, VS; Shprakh, VV | 1 |
| Ishchenko, AM; Ishchenko, MM; Shkrobot, SI | 1 |
| Burtsev, EM; Tugutov, AI | 1 |
2 review(s) available for vinpocetine and Chronic Disease
| Article | Year |
|---|---|
[The role of vinpocetine in the treatment of cerebrovascular diseases based in human studies].
Topics: Acute Disease; Brain Ischemia; Cerebrovascular Circulation; Cerebrovascular Disorders; Chronic Disease; Glucose; Hemorheology; Humans; Neuroprotective Agents; Nootropic Agents; Quality of Life; Stroke; Treatment Outcome; Vasodilator Agents; Vinca Alkaloids | 2007 |
[The use of vinpocetine in chronic disorders caused by cerebral hypoperfusion].
Topics: Calcium Channel Blockers; Cerebrovascular Circulation; Chronic Disease; Clinical Trials as Topic; Cognition; Cognition Disorders; Germany; Humans; Hypoxia, Brain; Italy; Japan; Memory; Memory Disorders; Neuroprotective Agents; Nootropic Agents; Severity of Illness Index; Sodium Channels; Treatment Outcome; Vasodilator Agents; Vinca Alkaloids | 2001 |
4 trial(s) available for vinpocetine and Chronic Disease
| Article | Year |
|---|---|
[A multicenter program on assessment of efficacy and safety of a new therapeutic scheme for patients with chronic cerebrovascular insufficiency].
Topics: Adult; Aged; Calcium Channel Blockers; Cerebrovascular Disorders; Chronic Disease; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Middle Aged; Neuroprotective Agents; Prospective Studies; Psychometrics; Quality of Life; Surveys and Questionnaires; Treatment Outcome; Vinca Alkaloids | 2009 |
[The new scheme of cavinton application to the treatment of chronic neurosensory loss of hearing].
Topics: Acoustic Impedance Tests; Administration, Oral; Adult; Aged; Calcium Channel Blockers; Chronic Disease; Dose-Response Relationship, Drug; Hearing; Hearing Loss, Sensorineural; Humans; Infusions, Intravenous; Middle Aged; Nootropic Agents; Treatment Outcome; Vinca Alkaloids | 2009 |
[Effect of vinpocetin on the hemorheologic parameters in patients with chronic cerebrovascular disease].
Topics: Aged; Antihypertensive Agents; Blood Viscosity; Brain Ischemia; Chronic Disease; Drug Administration Schedule; Erythrocyte Aggregation; Female; Hematocrit; Hemorheology; Humans; Infusions, Intravenous; Male; Middle Aged; Treatment Outcome; Vasodilator Agents; Vinca Alkaloids | 2003 |
Effects of vinpocetine on the redistribution of cerebral blood flow and glucose metabolism in chronic ischemic stroke patients: a PET study.
Topics: Brain Chemistry; Cerebrovascular Circulation; Chronic Disease; Double-Blind Method; Female; Functional Laterality; Glucose; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Stroke; Ultrasonography, Doppler, Transcranial; Vinca Alkaloids | 2005 |
12 other study(ies) available for vinpocetine and Chronic Disease
| Article | Year |
|---|---|
Multimodal therapy for chronic tinnitus.
Topics: Adult; Aged; Betahistine; Chronic Disease; Cinnarizine; Combined Modality Therapy; Dimenhydrinate; Drug Combinations; Drug Therapy, Combination; Female; Ginkgo biloba; Humans; Lidocaine; Low-Level Light Therapy; Male; Middle Aged; Pentoxifylline; Physical Therapy Modalities; Plant Extracts; Retrospective Studies; Tinnitus; Vinca Alkaloids | 2008 |
[The results of clinical study of cavinton efficacy inpatients with chronic brain ischemia].
Topics: Antihypertensive Agents; Brain Ischemia; Chronic Disease; Dose-Response Relationship, Drug; Follow-Up Studies; Humans; Inpatients; Middle Aged; Nootropic Agents; Treatment Outcome; Vinca Alkaloids | 2008 |
[Effect of cavinton forte on the cerebral hemodynamic and autoregulation mechanisms of cerebral blood flow in patients with chronic cerebral ischemia].
Topics: Administration, Oral; Aged; Aged, 80 and over; Brain Ischemia; Cerebrovascular Circulation; Chronic Disease; Dose-Response Relationship, Drug; Follow-Up Studies; Homeostasis; Humans; Regional Blood Flow; Treatment Outcome; Ultrasonography, Doppler, Transcranial; Vasodilator Agents; Vinca Alkaloids | 2009 |
[Endothelium-protective effects of vinpocetine, pentoxifylline and enalapril in patients with chronic brain ischemia].
Topics: Adult; Aged; Antihypertensive Agents; Brain Ischemia; Case-Control Studies; Cerebrovascular Circulation; Cholesterol; Chronic Disease; Dose-Response Relationship, Drug; Enalapril; Endothelium, Vascular; Fibrinogen; Humans; Middle Aged; Pentoxifylline; Treatment Outcome; Vasodilation; Vasodilator Agents; Vinca Alkaloids; von Willebrand Factor | 2011 |
[Effect of cavinton on the hemorheological parameters of chronic cerebrovascular patients].
Topics: Blood Viscosity; Cerebrovascular Circulation; Cerebrovascular Disorders; Chronic Disease; Erythrocyte Aggregation; Female; Fibrinogen; Follow-Up Studies; Humans; Injections, Intravenous; Male; Middle Aged; Neuroprotective Agents; Treatment Outcome; Vinca Alkaloids | 2006 |
[An effect of vinpocetine (cavinton) on endothelium function in patients with chronic cerebral ischemia].
Topics: Aged; Brachial Artery; Brain Ischemia; Calcium Channel Blockers; Cerebrovascular Circulation; Chronic Disease; Dose-Response Relationship, Drug; Endothelium, Vascular; Follow-Up Studies; Humans; Injections, Intravenous; Middle Aged; Treatment Outcome; Vasodilation; Vasodilator Agents; Vinca Alkaloids | 2006 |
[Diagnostics and treatment tactics for chronic cerebrovascular disorders with the use of single photon emission computed tomography].
Topics: Brain; Calcium Channel Blockers; Cerebrovascular Circulation; Cerebrovascular Disorders; Chronic Disease; Female; Humans; Male; Middle Aged; Tomography, Emission-Computed, Single-Photon; Vinca Alkaloids | 2008 |
[The effect of kavinton, trental, sermion and kurantil on the blood flow rate in individual segments of the cerebral arteries].
Topics: Blood Flow Velocity; Cerebral Arteries; Chronic Disease; Dipyridamole; Drug Evaluation; Female; Humans; Injections, Intravenous; Intracranial Arteriosclerosis; Male; Middle Aged; Myocardial Ischemia; Nicergoline; Pentoxifylline; Ultrasonography, Doppler, Transcranial; Vasodilator Agents; Vinca Alkaloids | 1994 |
[Functioning of the cerebral circulatory system in rabbits during hyperthermia].
Topics: Aminophylline; Animals; Blood-Brain Barrier; Body Temperature; Body Water; Brain; Carbon Dioxide; Cerebrovascular Circulation; Chronic Disease; Electrodes, Implanted; Fever; Flunarizine; Posture; Rabbits; Vasodilator Agents; Vinca Alkaloids | 1989 |
[Effectiveness of using cavinton in patients of different ages with chronic forms of cerebrovascular diseases (clinico-rheographic research)].
Topics: Aged; Aging; Cerebrovascular Circulation; Cerebrovascular Disorders; Chronic Disease; Drug Evaluation; Female; Humans; Hypertension; Intracranial Arteriosclerosis; Male; Middle Aged; Plethysmography, Impedance; Vasodilator Agents; Vinca Alkaloids | 1988 |
[Cavinton treatment of patients with chronic cerebral circulatory insufficiency].
Topics: Adult; Aged; Brain Ischemia; Chronic Disease; Female; Humans; Male; Middle Aged; Vinca Alkaloids | 1986 |
[Therapeutic effect of cavinton in chronic cerebral circulatory insufficiency].
Topics: Adult; Aged; Brain Ischemia; Cerebrovascular Circulation; Chronic Disease; Humans; Infusions, Parenteral; Middle Aged; Plethysmography, Impedance; Vertebrobasilar Insufficiency; Vinca Alkaloids | 1985 |